GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 116 filers reported holding GW PHARMACEUTICALS PLC in Q4 2015. The put-call ratio across all filers is 2.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $45,010,000 | -11.1% | 390,000 | -25.0% | 7.31% | +60.5% |
Q3 2020 | $50,645,000 | -8.3% | 520,232 | +15.6% | 4.56% | +3.2% |
Q2 2020 | $55,224,000 | +40.1% | 450,000 | 0.0% | 4.41% | +7.2% |
Q1 2020 | $39,407,000 | +166.0% | 450,000 | +217.6% | 4.12% | +219.1% |
Q4 2019 | $14,814,000 | +49.6% | 141,683 | +88.9% | 1.29% | -23.6% |
Q4 2017 | $9,901,000 | +213.4% | 75,000 | +215.1% | 1.69% | +109.6% |
Q3 2016 | $3,159,000 | -54.5% | 23,800 | -76.2% | 0.81% | -72.3% |
Q4 2015 | $6,944,000 | -62.7% | 100,000 | -50.9% | 2.91% | -60.4% |
Q3 2015 | $18,621,000 | – | 203,800 | – | 7.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |